Cargando…
Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus register
INTRODUCTION: In 2012, the Systemic Lupus International Collaborating Clinics (SLICC) network presented a new set of criteria (SLICC-12) to classify systemic lupus erythematosus (SLE). The present study is the first to evaluate the performance of SLICC-12 in an adult European study population. Thus,...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318183/ https://www.ncbi.nlm.nih.gov/pubmed/25575961 http://dx.doi.org/10.1186/s13075-015-0521-9 |
_version_ | 1782355817575481344 |
---|---|
author | Ighe, Anna Dahlström, Örjan Skogh, Thomas Sjöwall, Christopher |
author_facet | Ighe, Anna Dahlström, Örjan Skogh, Thomas Sjöwall, Christopher |
author_sort | Ighe, Anna |
collection | PubMed |
description | INTRODUCTION: In 2012, the Systemic Lupus International Collaborating Clinics (SLICC) network presented a new set of criteria (SLICC-12) to classify systemic lupus erythematosus (SLE). The present study is the first to evaluate the performance of SLICC-12 in an adult European study population. Thus, SLICC-12 criteria were applied to confirmed SLE cases in our regional SLE register as well as to individuals with a fair suspicion of systemic autoimmune disease who were referred to rheumatology specialists at our unit. METHODS: We included 243 confirmed SLE patients who met the 1982 American College of Rheumatology (ACR-82) classification criteria and/or the Fries ‘diagnostic principle’ (presence of antinuclear antibodies on at least one occasion plus involvement of at least two defined organ systems) and 55 controls with possible systemic autoimmune disease, including the presence of any SLE-related autoantibody. RESULTS: SLICC-12 showed a diagnostic sensitivity of 94% (95% confidence interval (CI), 0.90 to 0.96) compared with 90% (95% CI, 0.85 to 0.93) for the updated set of ACR criteria from 1997 (ACR-97), whereas ACR-82 failed to identify every fifth true SLE case. However, the disease specificity of SLICC-12 reached only 74% (95% CI, 0.60 to 0.84) and did not change much when involvement of at least two different organs was required as an indicator of systemic disease. In addition, SLICC-12 misclassified more of the controls compared to ACR-82, ACR-97 and Fries. CONCLUSIONS: Establishing a standard definition of SLE continues to challenge lupus researchers and clinicians. We confirm that SLICC-12 has advantages with regard to diagnostic sensitivity, whereas we found the diagnostic specificity to be surprisingly low. To accomplish increased sensitivity and specificity figures, a combination of criteria sets for clinical SLE studies should be considered. |
format | Online Article Text |
id | pubmed-4318183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-43181832015-02-06 Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus register Ighe, Anna Dahlström, Örjan Skogh, Thomas Sjöwall, Christopher Arthritis Res Ther Research Article INTRODUCTION: In 2012, the Systemic Lupus International Collaborating Clinics (SLICC) network presented a new set of criteria (SLICC-12) to classify systemic lupus erythematosus (SLE). The present study is the first to evaluate the performance of SLICC-12 in an adult European study population. Thus, SLICC-12 criteria were applied to confirmed SLE cases in our regional SLE register as well as to individuals with a fair suspicion of systemic autoimmune disease who were referred to rheumatology specialists at our unit. METHODS: We included 243 confirmed SLE patients who met the 1982 American College of Rheumatology (ACR-82) classification criteria and/or the Fries ‘diagnostic principle’ (presence of antinuclear antibodies on at least one occasion plus involvement of at least two defined organ systems) and 55 controls with possible systemic autoimmune disease, including the presence of any SLE-related autoantibody. RESULTS: SLICC-12 showed a diagnostic sensitivity of 94% (95% confidence interval (CI), 0.90 to 0.96) compared with 90% (95% CI, 0.85 to 0.93) for the updated set of ACR criteria from 1997 (ACR-97), whereas ACR-82 failed to identify every fifth true SLE case. However, the disease specificity of SLICC-12 reached only 74% (95% CI, 0.60 to 0.84) and did not change much when involvement of at least two different organs was required as an indicator of systemic disease. In addition, SLICC-12 misclassified more of the controls compared to ACR-82, ACR-97 and Fries. CONCLUSIONS: Establishing a standard definition of SLE continues to challenge lupus researchers and clinicians. We confirm that SLICC-12 has advantages with regard to diagnostic sensitivity, whereas we found the diagnostic specificity to be surprisingly low. To accomplish increased sensitivity and specificity figures, a combination of criteria sets for clinical SLE studies should be considered. BioMed Central 2015-01-10 2015 /pmc/articles/PMC4318183/ /pubmed/25575961 http://dx.doi.org/10.1186/s13075-015-0521-9 Text en © Ighe et al.; licensee BioMed Central. 2015 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Ighe, Anna Dahlström, Örjan Skogh, Thomas Sjöwall, Christopher Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus register |
title | Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus register |
title_full | Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus register |
title_fullStr | Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus register |
title_full_unstemmed | Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus register |
title_short | Application of the 2012 Systemic Lupus International Collaborating Clinics classification criteria to patients in a regional Swedish systemic lupus erythematosus register |
title_sort | application of the 2012 systemic lupus international collaborating clinics classification criteria to patients in a regional swedish systemic lupus erythematosus register |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318183/ https://www.ncbi.nlm.nih.gov/pubmed/25575961 http://dx.doi.org/10.1186/s13075-015-0521-9 |
work_keys_str_mv | AT igheanna applicationofthe2012systemiclupusinternationalcollaboratingclinicsclassificationcriteriatopatientsinaregionalswedishsystemiclupuserythematosusregister AT dahlstromorjan applicationofthe2012systemiclupusinternationalcollaboratingclinicsclassificationcriteriatopatientsinaregionalswedishsystemiclupuserythematosusregister AT skoghthomas applicationofthe2012systemiclupusinternationalcollaboratingclinicsclassificationcriteriatopatientsinaregionalswedishsystemiclupuserythematosusregister AT sjowallchristopher applicationofthe2012systemiclupusinternationalcollaboratingclinicsclassificationcriteriatopatientsinaregionalswedishsystemiclupuserythematosusregister |